Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields

The present study was designed to evaluate the binding and functional characterization of A(3) adenosine receptors in human neutrophils exposed to low frequency, low energy, pulsing electromagnetic fields (PEMFs). Great interest has grown concerning the use of PEMF in the clinical practice for therapeutic purposes strictly correlated with inflammatory conditions. Saturation experiments performed using the high affinity and selective A(3) adenosine antagonist 5N-(4-methoxyphenyl-carbamoyl)amino-8-propyl-2-(2-furyl)pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine ([3H]-MRE 3008F20) revealed a single class of binding sites with similar affinity in control and in PEMF treated human neutrophils (K(D)=2.36+/-0.16 and 2.45+/-0.15 nM, respectively). PEMFs treatment revealed that the receptor density was statistically increased (P<0.01) (B(max)=451+/-18 and 736+/-25fmolmg(-1) protein, respectively). Thermodynamic data indicated that [3H]-MRE 3008F20 binding in control and in PEMF-treated human neutrophils was entropy and enthalpy driven. Competition of radioligand binding by the high affinity A(3) receptor agonists, N(6)-(3-iodo-benzyl)-2-chloro-adenosine-5'-N-methyluronamide (Cl-IB-MECA) and N(6)-(3-iodo-benzyl)adenosine-5'-N-methyl-uronamide (IB-MECA), in the absence of PEMFs revealed high and low affinity values similar to those found in the presence of PEMFs. In both experimental conditions, the addition of GTP 100 microM shifted the competition binding curves of the agonists from a biphasic to a monophasic shape. In functional assays Cl-IB-MECA and IB-MECA were able to inhibit cyclic AMP accumulation and their potencies were statistically increased after exposure to PEMFs. These results indicate in human neutrophils treated with PEMFs the presence of significant alterations in the A(3) adenosine receptor density and functionality.

[1]  L. Worrall,et al.  Why do asthmatic subjects respond so strongly to inhaled adenosine? , 2001, Life sciences.

[2]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[3]  S. Maeda,et al.  Early effects of electrical stimulation on osteogenesis. , 1996, Bone.

[4]  Ruggero Cadossi,et al.  Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils , 2002, British journal of pharmacology.

[5]  K. Klotz,et al.  [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. , 2000, Molecular pharmacology.

[6]  K. Klotz,et al.  [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. , 2000, Molecular pharmacology.

[7]  K. Varani,et al.  Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line , 2001, British journal of pharmacology.

[8]  T. Kaku,et al.  Pulsed electromagnetic fields promote bone formation around dental implants inserted into the femur of rabbits. , 2000, Clinical oral implants research.

[9]  P. Fishman,et al.  Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor , 2001, Journal of cellular physiology.

[10]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[11]  E. Ongini,et al.  Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 binding , 1997, British journal of pharmacology.

[12]  M. T. Johnson,et al.  Effect of a wound healing electromagnetic field on inflammatory cytokine gene expression in rats. , 2001, Biomedical sciences instrumentation.

[13]  K. Jacobson,et al.  A physiological role of the adenosine A3 receptor: sustained cardioprotection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[15]  D. Pearson,et al.  Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release. , 1999, Arthritis and rheumatism.

[16]  K. Varani,et al.  Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding , 1996, British journal of pharmacology.

[17]  P. Fishman,et al.  Adenosine acts as a chemoprotective agent by stimulating G‐CSF production: A role for A1 and A3 adenosine receptors , 2000, Journal of cellular physiology.

[18]  A. Multani,et al.  The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. , 2001, Experimental cell research.

[19]  K. Varani,et al.  Binding thermodynamics of adenosine A2a receptor ligands. , 1995, Biochemical pharmacology.

[20]  F. Marinelli,et al.  Intramembrane protein distribution in cell cultures is affected by 50 Hz pulsed magnetic fields. , 1997, Bioelectromagnetics.

[21]  B. Bianco,et al.  Zeeman-Stark modeling of the RF EMF interaction with ligand binding. , 2000, Bioelectromagnetics.

[22]  E. Ongini,et al.  [3H]‐SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes , 1998, British journal of pharmacology.

[23]  J. Fozard,et al.  Mast cell degranulation following adenosine A3 receptor activation in rats. , 1996, European journal of pharmacology.

[24]  B. Cronstein Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.

[25]  P. Forsythe,et al.  Adenosine, mast cells and asthma , 1999, Inflammation Research.

[26]  F. Pezzetti,et al.  Effects of Pulsed Electromagnetic Fields on Human Articular Chondrocyte Proliferation , 2001, Connective tissue research.

[27]  S. Abramson,et al.  Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. , 1992, Journal of immunology.

[28]  D. Ferrari,et al.  Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells , 2001, British journal of pharmacology.

[29]  K. Varani,et al.  A3 Adenosine Receptors in Human Neutrophils and Promyelocytic HL60 Cells: A Pharmacological and Biochemical Study , 2002 .

[30]  P. Diniz,et al.  Effects of pulsed electromagnetic field (PEMF) stimulation on bone tissue like formation are dependent on the maturation stages of the osteoblasts , 2002, Bioelectromagnetics.

[31]  K. Jacobson,et al.  Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: neuronal and glial effects. , 1999, European journal of pharmacology.

[32]  Islam Ms,et al.  Pulsed electromagnetic fields for the treatment of bone fractures. , 1999 .

[33]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  G. Torelli,et al.  Lymphocytes and low‐frequency electromagnetic fields , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. IJzerman,et al.  Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. , 2001, Biochemical pharmacology.

[36]  M. Macdonald,et al.  Chondrocytes respond to adenosine via A(2)receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. , 2002, Osteoarthritis and cartilage.

[37]  C. Ezeamuzie,et al.  Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release , 1999, British journal of pharmacology.

[38]  P. Nguyên,et al.  Adenosine Inhibits Tissue Factor Expression by LPS-stimulated Human Monocytes: Involvement of the A3 Adenosine Receptor , 2002, Thrombosis and Haemostasis.

[39]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[40]  F. Pezzetti,et al.  Effects of Pulsed Electromagnetic Fields on Human Chondrocytes: An In Vitro Study , 1999, Calcified Tissue International.

[41]  K. Jacobson,et al.  Adenosine A3 receptors: novel ligands and paradoxical effects. , 1998, Trends in pharmacological sciences.